The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis

Objective. To explore the influence of TNF inhibitor (TNFi) therapy and rituximab (RTX) upon the incidence of cancer in patients with RA and prior malignancy. Methods. The study population comprised RA subjects with a prior malignancy reported to the UK national cancer registers, recruited to the Br...

Descripción completa

Detalles Bibliográficos
Autores principales: Silva-Fernández, Lucía, Lunt, Mark, Kearsley-Fleet, Lianne, Watson, Kath D., Dixon, William G., Symmons, Deborah P. M., Hyrich, Kimme L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088627/
https://www.ncbi.nlm.nih.gov/pubmed/27550304
http://dx.doi.org/10.1093/rheumatology/kew314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088627/
https://www.ncbi.nlm.nih.gov/pubmed/27550304
http://dx.doi.org/10.1093/rheumatology/kew314

Ejemplares similares